Cyclo Therapeutics, Inc. (NASDAQ:CYTH) Short Interest Update

Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Rating) was the recipient of a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 61,700 shares, a growth of 11.8% from the May 15th total of 55,200 shares. Based on an average trading volume of 137,900 shares, the […]

Related Keywords

Markus Sieger ,Renaissance Technologies ,Maxim Group ,Cyclo Therapeutics Inc ,Securities Exchange Commission ,Nasdaq ,Cyclo Therapeutics ,Get Rating ,Director Markus Sieger ,Exchange Commission ,Scott Fine ,Trappsol Cyclo ,Cyclo Therapeutics Daily ,